局部镇痛药的全球市场规模、份额和成长分析：按类型、治疗层级和分销管道 - 行业预测（2024-2031）

2022年，全球局部止痛药市场规模将为104.6亿美元，从2023年的111亿美元扩大到2031年的178.8亿美元，在预测期内（2024-2031年）预计复合年增长率为6.14% 。

导致局部镇痛治疗市场收益增加的主要因素之一是关节炎盛行率的上升。老年人口的成长和运动员对这些物品的强劲需求进一步推动了市场扩张。该报告对全球局部疼痛缓解市场进行了全面评估，包括对关键细分市场、趋势、驱动因素、限制因素、竞争格局以及影响市场动态的关键因素的深入研究。与糖尿病神经病变、关节炎和相关骨骼疾病以及癌症相关的疼痛盛行率不断上升，是全球局部止痛药市场快速成长的主要因素。此外，越来越多地使用局部镇痛药，其副作用比口服药物更少，也是市场扩张的动力。全球老化加剧和运动员对局部疼痛管理的需求不断增长是推动市场扩张的进一步因素。然而，也存在限制市场成长的因素，例如外用止痛药可能会刺激皮肤和产生难闻的气味。同时，局部镇痛业务拥有诱人的成长机会，包括局部治疗线上平台的出现以及新兴国家开拓的潜力。这些因素共同影响着市场的轨迹，并突显了在不断变化的环境中的机会和挑战。

目录

执行摘要

• 市场概况
• 转型

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模估算
• 市场假设与限制

母市场分析

• 市场概况
• 市场规模
• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

主要市场考察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• Start-Ups分析
• 原料分析
• 创新矩阵
• 研发线产品分析
• 总体经济指标
• 主要投资分析
• 关键成功因素
• 竞争程度

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 监管形势
• 波特的分析
• 对未来中断的特殊考虑

全球局部止痛药市场：按类型

• 市场概况
• 处方笺止痛药
• 非处方 (OTC) 止痛药

全球局部止痛药市场：依治疗层级

• 市场概况
• 非阿片类药物
• 非类固醇消炎剂（NSAIDS）
• 水杨酸甲酯
• 辣椒素
• Lidocaine
• 其他非鸦片类药物
• 阿片类药物
• Buprenornhine
• Fentanyl

全球局部镇痛药市场：依分销管道划分

• 市场概况
• 药局/药局
• 电子商务
• 零售店/杂货店

局部镇痛药的全球市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争形势

• 前5名企业对比
• 主要企业市场定位（2021年）
• 主要市场参与者所采取的策略
• 关键成功策略
• 近期市集活动
• 主要企业市场占有率（2021年）

主要企业简介

• Johnson & Johnson-USA
• GlaxoSmithKline plc-United Kingdom
• Novartis AG-Switzerland
• Pfizer Inc.-USA
• Reckitt Benckiser Group plc-United Kingdom
• Sun Pharmaceutical Industries Ltd.-India
• Endo International plc-Ireland
• Teva Pharmaceutical Industries Ltd.-Israel
• Sanofi SA-France
• Mylan NV（now part of Viatris Inc.）-USA

Global Topical Pain Relief Market size was valued at USD 10.46 billion in 2022 and is poised to grow from USD 11.10 billion in 2023 to USD 17.88 billion by 2031, growing at a CAGR of 6.14% during the forecast period (2024-2031).

One of the main factors contributing to the increased market revenue of topical pain relief treatments is the rise in the prevalence of arthritis. Further supporting market expansion are the growing geriatric population and the strong demand for these items among athletes. The report provides a thorough evaluation of the global topical pain relief market, including a thorough examination of key market segments, trends, drivers, constraints, the competitive environment, and critical factors influencing market dynamics. The increasing prevalence of diabetes neuropathy, arthritis and related bone disorders, and pain related to cancer are the main drivers of the topical pain relief market's enormous rise on a worldwide scale. The increasing use of topical painkillers, which often cause fewer negative effects than oral counterparts, is another motivating driver. The world's aging population boom and athletes' growing demand for topical pain management are two further factors driving market expansion. However, some factors, such as the possibility of skin irritation from topical painkillers and their unpleasant odour, limit the market's ability to grow. On the other hand, the topical pain relief business has attractive growth opportunities due to the emergence of online platforms for topical therapies and their unrealized potential in emerging nations. Together, these elements influence the market's trajectory, highlighting opportunities as well as problems in this ever-changing environment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Pain Relief Market Segmental Analysis

The therapeutic class, type, distribution channel, formulation, and region are the factors used to segment the global market for topical pain relief. Therapeutic classes include methyl salicylate, capsaicin, lidocaine, non-opioids, opioids, buprenorphine, fentanyl, and nonsteroidal anti-inflammatory drugs (NSAIDS). The market is divided into two categories based on type: over-the-counter and prescription pain relief. The market is divided into four segments based on the distribution channel: retail, drugstore, pharmacy, and grocery store. The market is divided into cream, gel, spray, patch, and other formulation categories. The market is divided into North America, Europe, Latin America, Asia-Pacific, the Middle East, and Africa based on geographic regions.

Drivers of the Global Topical Pain Relief Market

One of the main factors driving the topical pain relief market is the rising prevalence of chronic pain problems such neuropathic pain, arthritis, and musculoskeletal illnesses. Customers are looking for convenient, focused pain relief options that are localized.

Restraints in the Global Topical Pain Relief Market

Even though topical pain relievers are widely used, more substantial clinical research is required to confirm their safety and effectiveness, which will affect consumer acceptance and confidence.

Market Trends of the Global Topical Pain Relief Market

The market is seeing a change in topical pain management solutions toward those with natural and herbal ingredients. Customers are looking for goods that are seen to be healthier and have few synthetic ingredients.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Topical Pain Relief Market by Type

• Market Overview
• Prescription Pain Relief
• Over-the-counter (OTC) Pain Relief

Global Topical Pain Relief Market by Therapeutic Class

• Market Overview
• Non-opioids
• Nonsteroidal anti-inflammatory drug (NSAIDS)
• Methyl Salicylate
• Capsaicin
• Lidocaine
• Other Non-opioids
• Opioids
• Buprenorphine
• Fentanyl

Global Topical Pain Relief Market by Distribution Channel

• Market Overview
• Pharmacy & Drug Store
• e-Commerce
• Retail & Grocery Store

Global Topical Pain Relief Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Johnson & Johnson - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc - United Kingdom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc - United Kingdom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. - Israel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (now part of Viatris Inc.) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments